Investigating inflammatory memory in hematopoietic stem cells within the AML niche

A new research perspective was published in Oncotarget's Volume 15 on September 4, 2024, entitled, "Trained and ready - the case for an inflammatory memory for hematopoietic stem and progenitor cells in the AML niche."

As noted in the abstract of this paper, lifelong hematopoiesis is sustained by the crosstalk between hematopoietic stem and progenitor cells (HSPCs) and specialized bone marrow niches. Acute myeloid leukemia (AML) disrupts this balance, as leukemic blasts secrete factors that remodel the bone marrow into a self-reinforcing leukemic niche. Additionally, HSPCs are key components of the innate immune system. Over the past decade, elegant studies of infection and experimental inflammation have demonstrated the generation of an adoptively transferable, innate immune memory.

In their research perspective, Ding-Wen Chen, Eric K. Wafula, and Peter Kurre from the Department of Pediatrics, Comprehensive Bone Marrow Failure Center, Division of Hematology and the Department of Biomedical and Health Informatics at the Children's Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, discuss recent findings from their lab on the active role of HSPCs in AML and its potential implications.

"Considering the abundant evidence for AML associated inflammation, and the involvement of healthy HSPCs discussed in our study, the question arises whether sterile cancer-associated inflammation also has long-term functional consequences."

Source:
Journal reference:

Chen, D.-W., et al. (2024) Trained and ready - the case for an inflammatory memory for hematopoietic stem and progenitor cells in the AML niche. Oncotarget. doi.org/10.18632/oncotarget.28642.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Major funding boost aims to advance research on bone metastasis in breast and prostate cancers